Today: July 14, 2024
July 2, 2024
1 min read

Innovative Health Tech Startup Endo Health Lands Major US Backing


  • Korean digital healthcare startup Endo Health secures pre-seed funding from top-tier US investors, including Andreessen Horowitz and Krew Capital
  • The company plans to revolutionize chronic disease management with an AI-driven personalized healthcare service for diabetic and pre-diabetic patients

Korean digital healthcare startup Endo Health, based in Silicon Valley, has successfully secured pre-seed funding from prestigious US venture capital firms and renowned angel investors. The funding round, led by Andreessen Horowitz (a16z) and Krew Capital, with additional support from Anne Wojcicki, CEO of 23andMe, marks a significant milestone for the company as it gears up to transform chronic disease management.

The exact amount of the pre-seed investment remains undisclosed, but the total funding exceeds 1.3 billion won (USD 9.3 million). Endo Health focuses on developing an AI-driven personalized digital healthcare service tailored for diabetic and pre-diabetic patients with chronic diseases. By utilizing continuous glucose monitors and collecting real-time blood sugar and activity data, the service aims to help patients manage their conditions more effectively.

Insights from the company’s alpha test highlighted the importance of motivation in improving lifestyle habits, leading Endo Health to integrate a gamification strategy to make disease management accessible and enjoyable for users. With the global digital diabetes management market projected to reach a value of 17 trillion won, according to Grand View Research, Endo Health’s innovative approach aims to address the challenges patients face in self-management.

With the new funding, Endo Health plans to enhance its services and officially launch them in the third quarter of this year. The company will also participate in the ‘Speedrun’ acceleration program hosted by a16z, leveraging mentorship from industry leaders to facilitate its entry into the global market, starting with the US. CEO Hee-sang Yoon expressed a vision to change the paradigm of chronic disease management, starting with diabetes, and create a global digital healthcare startup that increases the average human lifespan.

Endo Health’s team of co-founders boasts diverse backgrounds in medicine, AI, and gaming, positioning the company for success in the evolving digital healthcare landscape.

Previous Story

Spotlight on Venture Secondaries: Step Into the Future

Next Story

Breaking: k-ID Raises Record $45M From Top Investors

Latest from Blog

Go toTop